Cardiovalve Ltd.
7
2
3
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
42.9%
3 terminated/withdrawn out of 7 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
Role: lead
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Role: lead
"TARGET 2.0 Study": Safety and Performance of the Cardiovalve TR Replacement System
Role: lead
"TARGET Study": Safety and Performance of the Cardiovalve TR Replacement System
Role: lead
Cardiovalve Transfemoral System - FIM Study
Role: lead
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Role: collaborator
Cardiovalve Transfemoral Mitral Valve System
Role: collaborator
All 7 trials loaded